Fixed Term For FDA Commissioner Could Bring Mixed Results For Industry
This article was originally published in The Tan Sheet
Executive Summary
Drug and device law attorneys say a fixed term for the FDA commissioner could stabilize oversight and attract leaders who are more like professional managers than political operatives, but might not insulate the agency from political influence.